Cargando…

A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia

BACKGROUND: The therapeutic effects of human embryonic stem cell-derived multipotent mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat model with atherosclerosis-induced chronic bladder ischemia (CBI) and associated mechanisms. METHODS: Sixteen-week-old male Sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Hwan Yeul, Shin, Jung Hyun, Yun, HongDuck, Ryu, Chae-Min, Lee, Seungun, Heo, Jinbeom, Lim, Jisun, Park, Juhyun, Hong, Ki-Sung, Chung, Hyung-Min, Shin, Dong-Myung, Choo, Myung-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599399/
https://www.ncbi.nlm.nih.gov/pubmed/34189670
http://dx.doi.org/10.1007/s12015-021-10204-z
_version_ 1784600944002990080
author Yu, Hwan Yeul
Shin, Jung Hyun
Yun, HongDuck
Ryu, Chae-Min
Lee, Seungun
Heo, Jinbeom
Lim, Jisun
Park, Juhyun
Hong, Ki-Sung
Chung, Hyung-Min
Shin, Dong-Myung
Choo, Myung-Soo
author_facet Yu, Hwan Yeul
Shin, Jung Hyun
Yun, HongDuck
Ryu, Chae-Min
Lee, Seungun
Heo, Jinbeom
Lim, Jisun
Park, Juhyun
Hong, Ki-Sung
Chung, Hyung-Min
Shin, Dong-Myung
Choo, Myung-Soo
author_sort Yu, Hwan Yeul
collection PubMed
description BACKGROUND: The therapeutic effects of human embryonic stem cell-derived multipotent mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat model with atherosclerosis-induced chronic bladder ischemia (CBI) and associated mechanisms. METHODS: Sixteen-week-old male Sprague–Dawley rats were divided into five groups (n = 10). The DUA groups underwent 30 bilateral repetitions of endothelial injury to the iliac arteries to induce CBI, while the sham control group underwent a sham operation. All rats used in this study received a 1.25% cholesterol diet for 8 weeks. M-MSCs at a density of 2.5, 5.0, or 10.0 × 10(5) cells (250 K, 500 K, or 1000 K; K = a thousand) were injected directly into the bladder 7 weeks post-injury, while the sham and DUA group were treated only with vehicle (phosphate buffer solution). One week after M-MSC injection, awake cystometry was performed on the rats. Then, the bladders were harvested, studied in an organ bath, and prepared for histological and gene expression analyses. RESULTS: CBI by iliac artery injury reproduced voiding defects characteristic of DUA with decreased micturition pressure, increased micturition interval, and a larger residual volume. The pathological DUA properties were improved by M-MSC treatment in a dose-dependent manner, with the 1000 K group producing the best efficacy. Histological analysis revealed that M-MSC therapy reduced CBI-induced injuries including bladder fibrosis, muscular loss, and apoptosis. Transplanted M-MSCs mainly engrafted as vimentin and NG2 positive pericytes rather than myocytes, leading to increased angiogenesis in the CBI bladder. Transcriptomes of the CBI-injured bladders were characterized by the complement system, inflammatory, and ion transport-related pathways, which were restored by M-MSC therapy. CONCLUSIONS: Single injection of M-MSCs directly into the bladder of a CBI-induced DUA rat model improved voiding profiles and repaired the bladder muscle atrophy in a dose-dependent manner. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12015-021-10204-z.
format Online
Article
Text
id pubmed-8599399
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-85993992021-11-24 A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia Yu, Hwan Yeul Shin, Jung Hyun Yun, HongDuck Ryu, Chae-Min Lee, Seungun Heo, Jinbeom Lim, Jisun Park, Juhyun Hong, Ki-Sung Chung, Hyung-Min Shin, Dong-Myung Choo, Myung-Soo Stem Cell Rev Rep Article BACKGROUND: The therapeutic effects of human embryonic stem cell-derived multipotent mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat model with atherosclerosis-induced chronic bladder ischemia (CBI) and associated mechanisms. METHODS: Sixteen-week-old male Sprague–Dawley rats were divided into five groups (n = 10). The DUA groups underwent 30 bilateral repetitions of endothelial injury to the iliac arteries to induce CBI, while the sham control group underwent a sham operation. All rats used in this study received a 1.25% cholesterol diet for 8 weeks. M-MSCs at a density of 2.5, 5.0, or 10.0 × 10(5) cells (250 K, 500 K, or 1000 K; K = a thousand) were injected directly into the bladder 7 weeks post-injury, while the sham and DUA group were treated only with vehicle (phosphate buffer solution). One week after M-MSC injection, awake cystometry was performed on the rats. Then, the bladders were harvested, studied in an organ bath, and prepared for histological and gene expression analyses. RESULTS: CBI by iliac artery injury reproduced voiding defects characteristic of DUA with decreased micturition pressure, increased micturition interval, and a larger residual volume. The pathological DUA properties were improved by M-MSC treatment in a dose-dependent manner, with the 1000 K group producing the best efficacy. Histological analysis revealed that M-MSC therapy reduced CBI-induced injuries including bladder fibrosis, muscular loss, and apoptosis. Transplanted M-MSCs mainly engrafted as vimentin and NG2 positive pericytes rather than myocytes, leading to increased angiogenesis in the CBI bladder. Transcriptomes of the CBI-injured bladders were characterized by the complement system, inflammatory, and ion transport-related pathways, which were restored by M-MSC therapy. CONCLUSIONS: Single injection of M-MSCs directly into the bladder of a CBI-induced DUA rat model improved voiding profiles and repaired the bladder muscle atrophy in a dose-dependent manner. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12015-021-10204-z. Springer US 2021-06-29 2021 /pmc/articles/PMC8599399/ /pubmed/34189670 http://dx.doi.org/10.1007/s12015-021-10204-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Yu, Hwan Yeul
Shin, Jung Hyun
Yun, HongDuck
Ryu, Chae-Min
Lee, Seungun
Heo, Jinbeom
Lim, Jisun
Park, Juhyun
Hong, Ki-Sung
Chung, Hyung-Min
Shin, Dong-Myung
Choo, Myung-Soo
A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
title A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
title_full A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
title_fullStr A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
title_full_unstemmed A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
title_short A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia
title_sort preclinical study of human embryonic stem cell-derived mesenchymal stem cells for treating detrusor underactivity by chronic bladder ischemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599399/
https://www.ncbi.nlm.nih.gov/pubmed/34189670
http://dx.doi.org/10.1007/s12015-021-10204-z
work_keys_str_mv AT yuhwanyeul apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT shinjunghyun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT yunhongduck apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT ryuchaemin apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT leeseungun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT heojinbeom apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT limjisun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT parkjuhyun apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT hongkisung apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT chunghyungmin apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT shindongmyung apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT choomyungsoo apreclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT yuhwanyeul preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT shinjunghyun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT yunhongduck preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT ryuchaemin preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT leeseungun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT heojinbeom preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT limjisun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT parkjuhyun preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT hongkisung preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT chunghyungmin preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT shindongmyung preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia
AT choomyungsoo preclinicalstudyofhumanembryonicstemcellderivedmesenchymalstemcellsfortreatingdetrusorunderactivitybychronicbladderischemia